The Clorox Company (CLX) Financials
CLX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 7.8 billion | 7.5 billion |
| March 31, 2026 | 6.4 billion | 6.3 billion |
| Dec. 31, 2025 | 5.6 billion | 5.6 billion |
| Sept. 30, 2025 | 5.5 billion | 5.4 billion |
CLX Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | ? | ? |
| March 31, 2026 | -165.0 million | 39.0 million |
| Dec. 31, 2025 | 269.0 million | 24.0 million |
| Sept. 30, 2025 | 57.0 million | 10.0 million |
CLX Net Income
| Date | Net Income |
|---|---|
| June 30, 2026 | ? |
| March 31, 2026 | 187.0 million |
| Dec. 31, 2025 | 157.0 million |
| Sept. 30, 2025 | 82.0 million |
CLX Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 143.0 million | 4.0 billion | 452.0 million |
| March 31, 2026 | 1.2 billion | 2.5 billion | 408.0 million |
| Dec. 31, 2025 | 227.0 million | 2.5 billion | 424.0 million |
| Sept. 30, 2025 | 166.0 million | 2.5 billion | 375.0 million |
CLX Shares Outstanding
CLX Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 32.0 million | -235.0 million | - |
| March 31, 2026 | 43.0 million | 27.0 million | 406.0 million | 177.0 million |
| Dec. 31, 2025 | 42.0 million | 29.0 million | 452.0 million | 190.0 million |
| Sept. 30, 2025 | 36.0 million | 28.0 million | 443.0 million | 166.0 million |
CLX Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 1.9 billion | 1.1 billion |
| March 31, 2026 | 1.7 billion | 948.0 million |
| Dec. 31, 2025 | 1.7 billion | 951.0 million |
| Sept. 30, 2025 | 1.4 billion | 833.0 million |
CLX Revenue by Segment
CLX
List: Champions
Price: $83.52
Dividend Yield: 5.92%
Forward Dividend Yield: 5.99%
Payout Ratio: 217.86%
Dividend Per Share: 5.00 USD
Earnings Per Share: 4.81 USD
P/E Ratio: 21.86
Exchange: NYQ
Sector: Consumer Defensive
Industry: Household & Personal Products
Country: United States
Volume: 5.2 million
Ebitda: 288.0 millionMarket Capitalization: 10.1 billion
Average Dividend Frequency: 4
Years Paying Dividends: 44
DGR3: 1.69%
DGR5: 2.70%
DGR10: 5.11%
DGR20: 7.85%